Finance 

Orchard Therapeutics (ORTX) is Up 55% YTD: Is New Highs Imminent?

Emile Ortega

There have been many biotech stocks that have managed to record significant gains so far this year and one of those is the Orchard Therapeutics (NASDAQ: ORTX) stock. The Orchard stock has gone up by as high as 55% this year so far and it might be a good idea for investors to take a closer look at the company.

Last week the company announced its financial results for the fourth quarter and although it performed well on the earnings per share front it did not have much of an effect on the stock price.

Orchard recorded earnings per share of $0.34, which not only reflected a year-on-year jump of as big as 26.09% but also beat analysts’ estimates of $0.35. On the other hand, the revenues went down by 100% to $0. It was a bit of a disappointment for the company and especially so since analysts had estimated that revenues were going to be $60,000.

Emile Ortega

Editor and Computer ExpertA hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.